# GRIPAP1

## Overview
GRIPAP1, or GRIP1 associated protein 1, is a gene that encodes a protein involved in intracellular signaling and trafficking, particularly within the nervous system. The protein, also known as GRASP1, is categorized as a signaling protein due to its role in the endosomal recycling of AMPA receptors, which is crucial for synaptic plasticity and function. This process is vital for synaptic organization and neurotransmitter release, impacting learning and memory mechanisms. GRIPAP1 interacts with glutamate receptor-interacting protein 1 (GRIP1) and is implicated in the regulation of synaptic receptor trafficking and actin cytoskeleton morphology, which are essential for brain development and function. The gene's involvement in these processes underscores its significance in neurodevelopmental and neurodegenerative conditions, as well as its potential role in certain cancers (Millar2003Yeast; Peppercorn2022Secreted).

## Structure
GRIPAP1, or GRIP1 associated protein 1, is a protein involved in cellular signaling pathways. The molecular structure of GRIPAP1 includes various domains that facilitate its interaction with other proteins. Notably, it contains PDZ domains, which are crucial for protein-protein interactions. These domains allow GRIPAP1 to bind with other proteins, playing a significant role in its function within signaling pathways.

The protein undergoes post-translational modifications, such as phosphorylation, which may regulate its activity and interactions. These modifications can influence the protein's function by altering its conformation or interaction capabilities.

GRIPAP1 also exhibits splice variants, leading to different isoforms. These isoforms can have distinct structural and functional properties, potentially affecting the protein's role in cellular processes. The presence of these variants suggests a level of complexity in the regulation and function of GRIPAP1, as different isoforms may be expressed in response to specific cellular conditions or signals. 

Overall, the structural features of GRIPAP1, including its domains and post-translational modifications, are integral to its role in cellular signaling and its ability to interact with other proteins.

## Function
GRIPAP1, also known as GRASP1, is a protein involved in intracellular signaling and trafficking processes, particularly in the context of synaptic function and plasticity. It plays a crucial role in the endosomal recycling of AMPA receptors, which is essential for maintaining synaptic plasticity and function. This process is vital for synaptic organization and neurotransmitter release, impacting memory mechanisms and potentially offering therapeutic targets for neurodegenerative diseases like Alzheimer's (Peppercorn2022Secreted).

GRIPAP1 is active in the cytoplasm and synapse, where it interacts with glutamate receptor-interacting protein 1 (GRIP1). This interaction is significant for the regulation of synaptic receptor trafficking, which is critical for proper neuronal communication and function (Millar2003Yeast). The protein is also implicated in signal transduction and may function predominantly at the cell membrane, playing a role in regulating actin cytoskeleton morphology. This regulation is important for brain development and function, including processes like cell migration, axon outgrowth, and synaptic connection formation (Millar2003Yeast).

In summary, GRIPAP1 is integral to synaptic function, influencing learning and memory through its involvement in receptor trafficking and cytoskeletal regulation.

## Clinical Significance
GRIPAP1 has been implicated in several diseases and conditions due to its role in cellular signaling and neuronal function. Alterations in the methylation of GRIPAP1 have been associated with autism spectrum disorder (ASD). A study identified GRIPAP1 as one of the genes with differential methylation in the placental DNA of newborns, suggesting its potential role in predicting ASD. This gene is involved in neuronal cytoskeleton organization, and disruptions in its pathways may contribute to ASD development (BahadoSingh2021Placental).

In cancer research, GRIPAP1 has been identified as a novel fusion partner in translocation renal cell carcinoma (tRCC) and papillary thyroid cancer (PTC). In tRCC, GRIPAP1 was found to fuse with TFE3, potentially playing a role in carcinogenesis (Classe2017Incidence). In PTC, an in-frame fusion between GRIPAP1 and RET was discovered, indicating its involvement in thyroid cancer (Du2023Mutational).

GRIPAP1 expression is also altered in neurological conditions. It was significantly downregulated in temporal lobe epilepsy with hippocampal sclerosis, suggesting its involvement in the pathophysiology of epilepsy (Gu2021Profiling). These findings highlight the clinical significance of GRIPAP1 in various diseases, particularly those affecting the nervous system and cancer.

## Interactions
GRIPAP1, also known as GRASP1, is involved in interactions with AMPA receptors, which are crucial for synaptic transmission and plasticity. It plays a role in the endosomal recycling of these receptors, suggesting interactions with components of the endosomal trafficking machinery (Peppercorn2022Secreted). GRIPAP1 has been identified as interacting with the human DISC1 gene, a protein implicated in brain development and function. This interaction was discovered through yeast two-hybrid screens, indicating a potential coiled-coil interaction motif between GRIPAP1 and DISC1 (Millar2003Yeast). In a rat model overexpressing the human DISC1 gene, GRIPAP1 was found to be involved in the transport of AMPA receptors to the synapse via NMDA receptor activation, highlighting its role in synaptic organization and function (Sialana2018Quantitative).

GRIPAP1 was also shortlisted for further investigation in a study exploring potential interactions with VPS33B, a protein involved in membrane trafficking processes. However, specific interactions between GRIPAP1 and VPS33B were not confirmed in this study (Hunter2017Proteomic). Despite its involvement in various cellular processes, detailed physical interactions of GRIPAP1 with other proteins or nucleic acids remain to be fully elucidated.


## References


[1. (Sialana2018Quantitative) Fernando J. Sialana, An-Li Wang, Benedetta Fazari, Martina Kristofova, Roman Smidak, Svenja V. Trossbach, Carsten Korth, Joseph P. Huston, Maria A. de Souza Silva, and Gert Lubec. Quantitative proteomics of synaptosomal fractions in a rat overexpressing human disc1 gene indicates profound synaptic dysregulation in the dorsal striatum. Frontiers in Molecular Neuroscience, February 2018. URL: http://dx.doi.org/10.3389/fnmol.2018.00026, doi:10.3389/fnmol.2018.00026. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2018.00026)

[2. (BahadoSingh2021Placental) Ray O. Bahado-Singh, Sangeetha Vishweswaraiah, Buket Aydas, and Uppala Radhakrishna. Placental dna methylation changes and the early prediction of autism in full-term newborns. PLOS ONE, 16(7):e0253340, July 2021. URL: http://dx.doi.org/10.1371/journal.pone.0253340, doi:10.1371/journal.pone.0253340. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0253340)

3. (Hunter2017Proteomic) Proteomic and biochemical comparison of the cellular interaction partners of human VPS33A and VPS33B. This article has 0 citations.

[4. (Gu2021Profiling) Yifei Gu, Hongmei Wu, Tianyu Wang, Shengkun Yu, Zhibin Han, Wang Zhang, Long Mu, Hongda Wang, Meng Na, Haiyang Wang, and Zhiguo Lin. Profiling analysis of circular rna and mrna in human temporal lobe epilepsy with hippocampal sclerosis ilae type 1. Cellular and Molecular Neurobiology, 42(8):2745–2755, August 2021. URL: http://dx.doi.org/10.1007/s10571-021-01136-w, doi:10.1007/s10571-021-01136-w. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10571-021-01136-w)

[5. (Millar2003Yeast) J.Kirsty Millar, Sheila Christie, and David J Porteous. Yeast two-hybrid screens implicate disc1 in brain development and function. Biochemical and Biophysical Research Communications, 311(4):1019–1025, November 2003. URL: http://dx.doi.org/10.1016/j.bbrc.2003.10.101, doi:10.1016/j.bbrc.2003.10.101. This article has 135 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2003.10.101)

[6. (Classe2017Incidence) Marion Classe, Gabriel G Malouf, Xiaoping Su, Hui Yao, Erika J Thompson, Denaha J Doss, Valérie Grégoire, Julien Lenobin, Jean‐Christophe Fantoni, Hélène Sudour‐Bonnange, David Khayat, Sébastien Aubert, Nizar M Tannir, and Xavier Leroy. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology, 70(7):1089–1097, March 2017. URL: http://dx.doi.org/10.1111/his.13167, doi:10.1111/his.13167. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/his.13167)

[7. (Du2023Mutational) Yaying Du, Shu Zhang, Gang Zhang, Jiaying Hu, Lianhua Zhao, Yuanyuan Xiong, Lu Shen, Rongrong Chen, Ke Ye, and Yan Xu. Mutational profiling of chinese patients with thyroid cancer. Frontiers in Endocrinology, July 2023. URL: http://dx.doi.org/10.3389/fendo.2023.1156999, doi:10.3389/fendo.2023.1156999. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2023.1156999)

[8. (Peppercorn2022Secreted) Katie Peppercorn, Torsten Kleffmann, Owen Jones, Stephanie Hughes, and Warren Tate. Secreted amyloid precursor protein alpha, a neuroprotective protein in the brain has widespread effects on the transcriptome and proteome of human inducible pluripotent stem cell-derived glutamatergic neurons related to memory mechanisms. Frontiers in Neuroscience, May 2022. URL: http://dx.doi.org/10.3389/fnins.2022.858524, doi:10.3389/fnins.2022.858524. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2022.858524)